HIND (Vyome Holdings) OCF Margin %: -4,487.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HIND Vyome Holdings Inc HIND
11 GF Score
Price $1.99
! 2 Warning Signs
View Full Analysis

What is Vyome Holdings OCF Margin %?

Vyome Holdings HIND -0.50% 11 OCF Margin % is -4,487.50% as of Mar. 2026. GuruFocus rates HIND with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, Vyome Holdings ranks worse than 87.68% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vyome Holdings's Cash Flow from Operations for the three months ended in Mar. 2026 was $-1.44 Mil. Vyome Holdings's Revenue for the three months ended in Mar. 2026 was $0.03 Mil. Therefore, Vyome Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was -4,487.50%.

As of today, Vyome Holdings's current OCF Yield % is -35.66%.

The historical rank and industry rank for Vyome Holdings's OCF Margin % or its related term are showing as below:

HIND' s OCF Margin % Range Over the Past 10 Years
Min: -1171.56   Med: -187.25   Max: -94.78
Current: -3234.42

During the past 4 years, the highest OCF Margin % of Vyome Holdings was -94.78%. The lowest was -1171.56%. And the median was -187.25%.

HIND's OCF Margin % is ranked worse than
87.68% of 950 companies
in the Biotechnology industry
Industry Median: -68.59 vs HIND: -3234.42

Vyome Holdings OCF Margin % Related Terms

Vyome Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vyome Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vyome Holdings OCF Margin % Chart

Vyome Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Margin %
-94.78 -135.58 -238.91 -1,171.56

Vyome Holdings Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -102.51 -594.00 -5,057.14 -3,994.59 -4,487.50

HIND vs CTXR, MBRX, AKTX: OCF Margin % Comparison

For the Biotechnology subindustry, Vyome Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vyome Holdings OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vyome Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Vyome Holdings's OCF Margin % falls into.


HIND
11GF Score
Vyome Holdings Inc HIND
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vyome Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vyome Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.749/0.32
=-1,171.56 %

Vyome Holdings's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.436/0.032
=-4,487.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -4,487.50% mean?
Vyome Holdings (HIND) has a OCF Margin % of -4,487.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vyome Holdings and its competitors. According to the industry distribution chart, Vyome Holdings ranks #833 out of 950 companies in the Biotechnology industry, placing it in the top 87.7%.
Is Vyome Holdings' OCF Margin % too high?
Vyome Holdings' current OCF Margin % is -4,487.50%. Based on the distribution chart, Vyome Holdings ranks #833 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vyome Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Vyome Holdings' OCF Margin % compare to CTXR and MBRX?
According to the Biotechnology industry distribution chart, Vyome Holdings ranks #833 out of 950 companies for OCF Margin %. This places Vyome Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vyome Holdings and its competitors. Vyome Holdings's current OCF Margin % is -4,487.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vyome Holdings stock overvalued right now?
Vyome Holdings (HIND) has a current OCF Margin % of -4,487.50%. The current OCF Margin % is -4,487.50%. Vyome Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vyome Holdings (HIND), the current OCF Margin % is -4,487.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vyome Holdings Business Description

Address Harvard Square, Suite 400, One Mifflin Place, Cambridge, MA, USA, 02138
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
11GF Score

Get the complete analysis for HIND

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.99
Price